Cargando…
The Epigenomics of Pituitary Adenoma
Background: The vast majority of pituitary tumors are benign and behave accordingly; however, a fraction are invasive and are more aggressive, with a very small fraction being frankly malignant. The cellular pathways that drive transformation in pituitary neoplasms are poorly characterized, and curr...
Autores principales: | Hauser, Blake M., Lau, Ashley, Gupta, Saksham, Bi, Wenya Linda, Dunn, Ian F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6527758/ https://www.ncbi.nlm.nih.gov/pubmed/31139150 http://dx.doi.org/10.3389/fendo.2019.00290 |
Ejemplares similares
-
The Progress of Immunotherapy in Refractory Pituitary Adenomas and Pituitary Carcinomas
por: Dai, Congxin, et al.
Publicado: (2020) -
The Treatment of Refractory Pituitary Adenomas
por: Dai, Congxin, et al.
Publicado: (2019) -
Dopamine Agonists for Pituitary Adenomas
por: Cooper, Odelia, et al.
Publicado: (2018) -
Progress in the Diagnosis and Classification of Pituitary Adenomas
por: Syro, Luis V., et al.
Publicado: (2015) -
Editorial: Targeted Therapy for Pituitary Adenomas
por: Araki, Takako, et al.
Publicado: (2019)